should not hold any position in another business of the same kind or a competitor company. The shareholders shall have basic rights including the right to receive dividends, the right to attend
should not hold any position in another business of the same kind or a competitor company. The shareholders shall have basic rights including the right to receive dividends, the right to attend
considered a positive factor that shall enable the Company's operating performance to grow continually in the future. 2019 was considered the year that the Company had a remarkable performance and achieved the
Government. According to the increased of the market competition both of the competitor and the pricing, some project could not continue to extend the services. 2.2 Revenue from Contact Center Facility
the economy using significant quantities of lime are also showing remarkable growth. The steel industry continued to expand more than 10% year on year. In the construction sector the use of autoclaved
Bt798.65mn, decreasing 5.2% YoY and 2.5% QoQ. The YoY decreased was mainly from declining in mobile top up value which the result of 3 factors: The competitor, the campaign “prepaid to postpaid” of mobile
products that has not yet the competitor. And has been researching and good testing. 4. Details of acquired assets Details of the BS Myco Biotech Company Limited as follows: 4.1 General information
increased use of autoclaved aerated concrete blocks as Thailand follows a global trend. The nonferrous mining segment in our key export market Laos remains strong however as a new competitor comes on stream
and Analysis EXECUTIVE SUMMARY ABBREVIATION & OUR PROJECTSFINANCIAL PERFORMANCE FINANCIAL POSITION PROGRESS OF PROJECTS UNDER CONSTRUCTION EXECUTIVE SUMMARY 1 2019: A remarkable year with 40% capacity
growing revenue to THB 11,223 million with the Normalized Net Profit (NNP) of THB 1,158 million and NNP-owner of the parent of THB 682 million, growing 54.0% y-on-y. This remarkable performance came from 1